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The human body is a highly complex system operating over several spatio-
temporal scales. Advances is measurement techniques, particularly the ad-
vent of high through-put omics technologies, in recent decades has greatly
improved our understanding of the human system, and how the biological
entities in each sub-network from cells, to tissues and organs interact to give
rise to systemic responses. However, how to effectively process, integrate,
and analyse this often very high dimensional data presents poses one of the
biggest challenges to biological researches today. In this thesis, “Modelling
the Dynamics in Time Series of Metabolomics and Transcriptomics Data” we
have focused on a range of computational approaches that allow multivariate
time series of biological data to be integrated, analysed, and interpreted.
While the challenges of analysing time series data are common to several
biological disciplines in this thesis we have elected to focus on two specific
cases; the minimally invasive assessment of metabolic health in the obese
system and alternatives to animal testing in toxicological screening.
Nevertheless, the approaches used in this thesis can be generalised to several
biological disciplines. Moreover, all chapters of this thesis re-use existing
data, generating novel insights from previously published data.
Minimally invasive assessment of metabolic health
Our increasing sedentary lifestyle has given rise to an obesity
epidemic, with approximately 2.1 billion adults worldwide being
overweight or obese [1]. Overweight and obesity greatly increases the
risk for the development of non-communicable diseases including type 2
diabetes mellitus (T2DM), cardiovascular diseases, and certain cancers [2-4].
These conditions not only adversely impact the life of the sufferers and their
families, but also have a greater socio-economic impact; with the health care
costs as well as loss of productivity associated with T2DM in the Netherlands
alone being estimated a 4 billion euro annually [5]. Randomized controlled
clinical trials into nutritional and lifestyle interventions are plagued by a
considerable heterogeneity in response. Consequently, despite considerable
research into lifestyle interventions over several decades, the best practice
guidelines for nutritional intervention have not altered significantly.
The success of a nutritional or lifestyle intervention in typically assessed by
over-all weight loss, or loss in fat mass. However, increasingly researchers
are looking beyond simple weight loss and looking at improvements in
metabolic health as the best metric for intervention success. Nevertheless,
how we assess metabolic health still poses many challenges, with many
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of the gold standard measurements, such a clamp-techniques, being
costly and highly invasive. In Chapter 3 we propose a physiology based
computational model of adipose tissue metabolism. This model integrates
postprandial response of several metabolites to quantify dynamic features of
adipose tissue metabolism that are not directly measurable. Applying our
model to data collected before and after a nutritional intervention reveals
a large increase in adipose tissue specific insulin sensitivity coupled with
significant increases in the mobilisation of free fatty acids and glycerol
from the adipose tissue following caloric restriction. These alterations in
adipose tissue metabolism were not evident using more traditional area
under the curve techniques to assess the meal responses. In this way the
computational models produced in this thesis provide researchers with a
more sensitive measure of metabolic resilience that can be applied minimally
invasive meal challenge test data. This greater understanding of how an
individual responds to a particular diet intervention at a mechanistic level
can support clinicians in designing more personalised lifestyle interventions
with the potential to achieve greater and more sustainable weight loss and
improvements in health for the individual, while also helping to alleviate the
societal burden of the current obesity epidemic.
Recent studies have shown that certain phenotypical subgroups defined
based on insulin resistance or glucose tolerance status may be more
responsive to particular diet interventions, experiencing greater and more
sustained weight loss [6,7]. However, the current gold standard measure
for assessing insulin resistance is the hyperinsulinemic-euglycaemic
clamp. Such clamp techniques are highly invasive and time-consuming,
consequently it is prohibitive to apply these clamp techniques in clinics
or in large populations. In Chapter 2 we introduce the MISI Calculator,
an application that allows researchers and clinicians to quantify skeletal
muscle specific insulin resistance using oral glucose tolerance test data.
The MISI Calculator is available as a stand-alone application with a
user-friendly graphical user interface, allowing clinicians and biological
researchers to calculate the index without need for programming experience
or potentially expensive licensed software. In this way tissue specific
insulin resistance indices can be quantified using minimally invasive
clinical measurements. At the time of writing this thesis, multiple
intervention studies are making use of our MISI Calculator to facilitate the
standardised calculation of MISI. We also envision, that with increased
used of our MISI Calculator, applying the standardise MISI score to
a variety of study populations, clinically relevant insulin resistant
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thresholds can be identified as has been done in that past with the well-
established indices of whole body insulin resistance HOMA-IR and Matsuda.
Alternatives to animal testing in toxicological
screening
The current gold standard for assessing novel compounds or
candidate drugs for potential adverse outcomes in humans is the two-year
rodent in vivo bio-assay. In recent years, there has been growing ethical
concerns surrounding the number of animals being used in toxicological
screening giving rise the to the adoption of the 3Rs principle of replacement,
refinement, and reduction of animal testing. The 2006 EU Regulation on
the Registration, Evaluation, Authorisation and Restriction of Chemicals
(REACH) legislation states
“The Commission, Member States, industry and other stakeholder should continue
to contribute to the promotion of alternative test methods on an international and
national level including computer supported methodologies, in vitro methodologies,
as appropriate, those based on toxicogenomics, and other relevant methodologies.”
This desire for alternatives to animal testing has given rise to the development
of a slew of in vitro assays primarily utilising genomics technologies. While
these in vitro toxicogenomic assays have been shown to have good predictive
power in discriminating between subclasses of carcinogenicity [8,9] they can
differ greatly in terms of functionality and signalling from the tissues they
represent limiting their use for mechanistic interpretation.
In Chapters 4 and 5 we demonstrate that deep neural networks, particularly
those with a bottleneck architectures, are capable not only of translating gene
expression patterns from rat to human in vitro but also from in vitro to in vivo
in rats. While this was an initial pilot study, using data from just a single
toxicogenomics data base, our initial positive results show the potential of
bottleneck deep learning architectures for translating in vitro gene expression
patters to the human in vivo system, in line with the REACH guidelines. Fu-
ture research, aggregating gene expression data from several toxicology data
bases as well as public gene expression repositories can be used to expand
the scope of our model. Looking at genome wide changes in gene expres-
sion, allowing in vitro gene expression from human cell line models be di-
rectly translated to the human in vivo system could greatly reduce the need
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for animal testing. Moreover, as well as being expensive and time consum-
ing the current animal testing protocols have been shown to be a very poor
predictor of adverse outcomes in the human system, with a recent study in-
dicating that just 43% of the toxic effects of pharmaceutical compounds in
human were correctly predicted by animal testing [10]. The availability of
human in vitro assays combined with computational models that can reliably
predict adverse outcomes in humans would greatly accelerate drug devel-
opment both in terms of cost and quality. Beyond the field of toxicity as-
sessment, these bottleneck neural networks are increasingly being applied to
gene expression data sets in a range of biological disciplines as a powerful
tool for dimensionality reduction
Transfer learning methods, as applied in Chapter 5, allow the wealth of data
available for well studied model organisms or pathologies to be re-used to
study other disease states. This not only, reduces the need for to generate
large volumes of data for each instance, which may involve laborious and
costly experiments, but is particularly beneficial in the case of rare diseases
when it is not be possible to collect sufficient volumes of data to train a
model. These transfer learning principles are readily being utilised in
medical image analysis, where large, well labelled image data sets are being
exploited to train models for tumor detection or tissue segmentation in
medical images [11].
Open source Softwear
In order for computational models to be useable, it is essential
that the source code underlying the model is made publicly accessible
along with the published results. This is not only necessary to ensure
reproducibility of the results, but also to allow other researchers to
readily apply the models on their own data and also build upon and
extend published models. In this thesis we evaluated several published
models, however the underlying code was rarely supplied with the
publication, forcing us to make several assumptions on parameter values
and initial conditions when implementing the models ourselves. Each
chapter in this these introduces a novel computational model. To ensure
others can benefit from these models and approaches the source code
for all chapters is publicly accessible from my own GitHub repository
(https://github.com/shauna-odonovan) as well as in replication packages
provided in the supplementary material each publication. The models and
software described in this these are already being reused in multiple new
171
Valorisation
research projects.
Conclusions
In conclusion, I believe that greater cross discipline collaboration,
where researchers can benefit from each other’s expertise and work is
essential to move scientific research forward faster. In particular, I believe
computational models can provide a far more sensitive tool for biological
researchers to integrate and analyse time series of omics measurements
than current cruder approaches, providing predictive tools that can be more
rapidly translated to the clinic. In addition, computational models can allow
use to re-use available data, integrating it with existing knowledge, to infer
information about interactions in the human body that may not be readily
accessible for sampling.
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